Value proposition

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.

Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible.

The North America organization includes three offices in New Jersey and California that focus on drug discovery, product development, and commercialization. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives.

Our growth in North America relies on entrepreneurial team players who are willing to share their expertise and ideas in an environment that prioritizes innovation, diversity, integrity and “wa.” Each person plays a significant role in shaping the work we do and the results we deliver.

Oncology, Oncology Supportive Care, Immunotherapy, Parkinson's Disease, Central Nervous System, Neurology, Hematology, biotechnology, antibodies, drug discovery, clinical development, Rare Disease, Pharmaceuticals, Specialty Pharmaceuticals, Patients, Pharmaceutical, Medicine, Movement Disorders, and Specialty Care